Efficacy and safety of liposomal amphotericin B (AmBisome) for visceral leishmaniasis in endemic developing countries. JD Berman, R Badaro, CP Thakur, KM Wasunna, K Behbehani, ... Bulletin of the World Health Organization 76 (1), 25, 1998 | 219 | 1998 |
Do national medicinal drug policies and essential drug programs improve drug use?: a review of experiences in developing countries S Ratanawijitrasin, SB Soumerai, K Weerasuriya Social Science & Medicine 53 (7), 831-844, 2001 | 121 | 2001 |
β-adrenoceptor blockade and migraine K Weerasuriya, L Patel, P Turner Cephalalgia 2 (1), 33-45, 1982 | 62 | 1982 |
What can consumer adverse drug reaction reporting add to existing health professional-based systems? Focus on the developing world RBM Fernandopulle, K Weerasuriya Drug safety 26, 219-225, 2003 | 54 | 2003 |
Introduction: priority setting, equitable access and public involvement in health care A Weale, K Kieslich, P Littlejohns, A Tugendhaft, E Tumilty, K Weerasuriya, ... Journal of Health Organization and Management 30 (5), 736-750, 2016 | 50 | 2016 |
Preliminary clinical pharmacological studies of S3341, a new hypotensive agent, and comparison with clonidine in normal males K Weerasuriya, E Shaw, P Turner European journal of clinical pharmacology 27, 281-286, 1984 | 45 | 1984 |
The Lao national drug policy: lessons along the journey. C Paphassarang, G Tomson The Lancet 345 (8947), 433-435, 1995 | 42 | 1995 |
Alpha2-Adrenoceptor Agonists Stimulate Growth Hormone Secretion but Have No Acute Effects on Plasma Cortisol under Basal Conditions A Grossman, K Weerasuriya, S Al-Damluji, P Turner, GM Besser Hormone Research in Paediatrics 25 (2), 65-71, 1987 | 35 | 1987 |
Correction of systolic time intervals for heart rate: a comparison of individual with population derived regression equations. SJ Warrington, K Weerasuriya, CD Burgess British journal of clinical pharmacology 26 (2), 155-165, 1988 | 33 | 1988 |
Patterns of public participation: opportunity structures and mobilization from a cross-national perspective J Slutsky, E Tumilty, C Max, L Lu, S Tantivess, RC Hauegen, JA Whitty, ... Journal of Health Organization and Management 30 (5), 751-768, 2016 | 30 | 2016 |
Debrisoquine and mephenytoin oxidation in Sinhalese: a population study. K Weerasuriya, RL Jayakody, CA Smith, CR Wolf, GT Tucker, MS Lennard British journal of clinical pharmacology 38 (5), 466-470, 1994 | 27 | 1994 |
WHO Expert Committee on specifications for pharmaceutical preparations I Addae-Mensah, K Bremer, AA Haggag, J Shaohong, A Poompanich, ... Technical Report Series-World Health Organization, Geneva, i-136-i-136, 2003 | 25 | 2003 |
The curious case of zinc for diarrhea: Unavailable, unprescribed, and unused B Gitanjali, K Weerasuriya Journal of Pharmacology and Pharmacotherapeutics 2 (4), 225-229, 2011 | 20 | 2011 |
Containing antimicrobial resistance: a renewed effort K Weerasuriya, J Stelling, TF O'Brien Bulletin of the World Health Organization 88 (12), 878-878, 2010 | 16 | 2010 |
Essential drugs and registration of pharmaceuticals: the Sri Lankan experience. K Weerasuriya Bulletin of the World Health Organization 71 (2), 229, 1993 | 15 | 1993 |
Registration of new drugs in developing countries K Weerasuriya The Lancet 353 (9170), 2161-2162, 1999 | 13 | 1999 |
Renovar los esfuerzos de contención de la resistencia a los antimicrobianos K Weerasuriya, J Stelling, TF O’Brie Boletín de la Organización Mundial de la Salud 88, 878, 2010 | 12 | 2010 |
Effect of cimetidine and ranitidine on propranolol clearance L Patel, K Weerasuriya British Journal of Clinical Pharmacology 15 (1), P152-P152, 1983 | 12 | 1983 |
Efficacy of a five-day course of primaquine in preventing relapses in Plasmodium vivax malaria--a pilot study. BMR Fernandopulle, CL Weeraratne, K Weerasuriya, ND Karunaweera Ceylon Med J, 2003 | 8 | 2003 |
The pharmacokinetics of lysine theophylline, a new soluble theophylline, in human volunteers A Johnston, ME Aldhous, A Hedges, K Weerasuriya, A Freedman, ... Postgraduate Medical Journal 59 (688), 86-87, 1983 | 8 | 1983 |